BEST LAWRENCE C 4
4 · HAEMONETICS CORP · Filed May 7, 2013
Insider Transaction Report
Form 4
BEST LAWRENCE C
Director
Transactions
- Exercise/Conversion
Common Stock
2013-05-03$26.38/sh+12,000$316,560→ 20,352 total - Sale
Common Stock
2013-05-03$38.32/sh−12,000$459,830→ 8,352 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-05-03−12,000→ 0 totalExercise: $26.38From: 2006-05-05Exp: 2013-05-05→ Common Stock (12,000 underlying)
Holdings
- 9,184
Non-Qualified Stock Option (right to buy)
Exercise: $24.96From: 2008-08-01Exp: 2014-08-01→ Common Stock (9,184 underlying) - 8,580
Non-Qualified Stock Option (right to buy)
Exercise: $27.24From: 2011-07-29Exp: 2017-07-29→ Common Stock (8,580 underlying) - 11,328
Non-Qualified Stock Option (right to buy)
Exercise: $29.23From: 2009-07-31Exp: 2018-07-31→ Common Stock (11,328 underlying) - 11,758
Non-Qualified Stock Option (right to buy)
Exercise: $29.72From: 2010-07-30Exp: 2016-07-30→ Common Stock (11,758 underlying) - 7,118
Non-Qualified Stock Option (right to buy)
Exercise: $34.41From: 2012-07-21Exp: 2018-07-21→ Common Stock (7,118 underlying) - 8,196
Non-Qualified Stock Option (right to buy)
Exercise: $36.37From: 2013-07-27Exp: 2019-07-27→ Common Stock (8,196 underlying)
Footnotes (3)
- [F1]Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
- [F2]Grant to reporting person of right to buy shares of common stock exercisable immediately.
- [F3]Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.